Today, the district court for the Western District of Texas granted the government’s motion to dismiss the lawsuit brought by PhRMA and other organizations challenging the Drug Price Negotiation Program of the Inflation...more
2/13/2024
/ AstraZeneca ,
Boehringer ,
Bristol-Myers Squibb ,
Centers for Medicare & Medicaid Services (CMS) ,
Chamber of Commerce ,
Department of Health and Human Services (HHS) ,
Dismissals ,
Drug Pricing ,
Inflation Reduction Act (IRA) ,
Janssen Pharmaceuticals ,
Medicare ,
Medicare Act ,
Merck ,
Novartis ,
Novo Nordisk ,
Pharmaceutical Industry ,
PHRMA ,
Prescription Drugs ,
Secretary of HHS
Denial of Motion to Dismiss and Motion for Preliminary Injunction in Chambers of Commerce case -
On Friday, September 29, the court in Dayton Area Chamber of Commerce et al. v. Becerra et al. (S.D. Ohio, Judge Newman)...more
10/3/2023
/ Administrative Procedure Act ,
Amicus Briefs ,
Centers for Medicare & Medicaid Services (CMS) ,
Contract Negotiations ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Due Process ,
Fifth Amendment ,
First Amendment ,
Inflation Reduction Act (IRA) ,
Medicare ,
Pharmaceutical Industry ,
Prescription Drugs ,
State Attorneys General
HHS has announced the ten drugs that will be included in the first year of the Inflation Reduction Act’s new Drug Price Negotiation Program....more
The Inflation Reduction Act’s Medicare Drug Price Negotiation Program will kick off next week. The statute sets a deadline of September 1, 2023 for the Secretary of Health and Human Services (HHS) to publish a list of the 10...more